http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106987634-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2017-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106987634-B |
| titleOfInvention | Application of plasma exogenic miRNAs in preparation of kit for early diagnosis of primary liver cancer |
| abstract | The invention discloses application of plasma exogenic miRNAs in preparation of a kit for early diagnosis of primary liver cancer, wherein the plasma exogenic miRNAs consist of hsa-miR-466, hsa-miR-296-5p and hsa-miR-613. The plasma exosome-derived miRNAs hsa-miR-466, hsa-miR-296-5p and hsa-miR-613 provided by the invention are jointly used for diagnosing primary liver cancer and non-primary liver cancer (including benign liver diseases and healthy controls), have excellent diagnosis performance, high accuracy and sensitivity and strong specificity, and can be used for developing a diagnosis kit for early diagnosis of primary liver cancer. |
| priorityDate | 2017-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 16.